ConductScience.org, home

Paper38487532

The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report.

Deng W and 2 others. Front Immunol, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report. Papers, record 38487532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38487532

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The occurrence of asthma in an extensive-stage small-cell lung cancer patient after combination therapy with atezolizumab and anlotinib: a case report.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Case Reports, Research Support, Non-U.S. Gov't, Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.47, provisional
iCite
Revised in PubMed
2024-04-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deng WWang
2Chen JJuan
3Deng XYXin-Yu

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
AsthmaMajor topic
Small Cell Lung CarcinomaMajor topic
IndolesMajor topic
QuinolinesMajor topic
Antibodies, Monoclonal, HumanizedMajor topic
Female
Humans
Middle Aged
Combined Modality Therapy
Immune Checkpoint Inhibitors
Tumor Microenvironment

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128953502Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.Int J Gynecol Cancer2018https://conductscience.org/library/papers/28953502PubMed
229656747Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.Lung Cancer2018https://conductscience.org/library/papers/29656747PubMed
334395243Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer.Front Oncol2021https://conductscience.org/library/papers/34395243PubMed
431616186Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer.Cancer Manag Res2019https://conductscience.org/library/papers/31616186PubMed
533916438Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.Int J Mol Sci2021https://conductscience.org/library/papers/33916438PubMed
611444391VEGF as a mediator of tumor-associated immunodeficiency.Immunol Res2001https://conductscience.org/library/papers/11444391PubMed
728945837Nivolumab-induced asthma in a patient with non-small-cell lung cancer.Ann Oncol2017https://conductscience.org/library/papers/28945837PubMed
832983126Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment.Front Immunol2020https://conductscience.org/library/papers/32983126PubMed
922855687Therapeutical measures to control airway tolerance in asthma and lung cancer.Front Immunol2012https://conductscience.org/library/papers/22855687PubMed
1030178633Regulatory T cells and asthma.J Zhejiang Univ Sci B2018https://conductscience.org/library/papers/30178633PubMed
1128865147Differential regulation of PD-1 and its ligands in allergic asthma.Clin Exp Allergy2017https://conductscience.org/library/papers/28865147PubMed
1229654146Role of PD-1 during effector CD8 T cell differentiation.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29654146PubMed
1331078775Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer.J Thorac Oncol2019https://conductscience.org/library/papers/31078775PubMed
1434570052Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 Therapy.J Immunother2022https://conductscience.org/library/papers/34570052PubMed
1532197856Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes.Clin Lung Cancer2020https://conductscience.org/library/papers/32197856PubMed
1629774034Targeting VEGF/VEGFR to Modulate Antitumor Immunity.Front Immunol2018https://conductscience.org/library/papers/29774034PubMed
1733538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
1811015443Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.J Exp Med2000https://conductscience.org/library/papers/11015443PubMed
1924263240Neuropilin 1: function and therapeutic potential in cancer.Cancer Immunol Immunother2014https://conductscience.org/library/papers/24263240PubMed
2031046803Emerging therapies for small cell lung cancer.J Hematol Oncol2019https://conductscience.org/library/papers/31046803PubMed

See all 47 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40803852Clinical and Pathophysiological Characteristics of Patients in Whom Asthma Developed during Treatment with Immune Checkpoint Inhibitors: A Retrospective Single-center Study.Intern Med2026https://conductscience.org/library/papers/40803852PubMed
40766328Successful management of chronic eosinophilic pneumonia triggered by immune checkpoint inhibitor: a case report and literature review.Front Immunol2025https://conductscience.org/library/papers/40766328PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38487532

GET https://conductscience.org/api/papers/v1/38487532/references?page=2